← Back to Search

Texting Intervention for Diabetes

N/A
Waitlist Available
Led By Stephanie L Shimada, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month follow up
Awards & highlights
No Placebo-Only Group

Summary

This trial will help to develop a new customizable, interactive texting intervention called DD-TXT that allows Veterans to choose what kinds of diabetes self-management support they need, and when. This diabetes support will be provided to Veterans through "Annie", a new VA texting system for self-management support.

Who is the study for?
This trial is for Veterans with type 2 diabetes who have struggled to control their blood sugar levels. They must be scheduled for a future appointment, able to text, and not visually impaired. Participants need access to a cell phone or smartphone and at least four VA outpatient visits in the past year.
What is being tested?
The study tests DD-TXT, an interactive texting intervention that helps Veterans manage their diabetes via 'Annie', a VA texting system. It's compared against DSE, an education-only text based on a diabetes workbook. Patients are randomly assigned to one of these two interventions.
What are the potential side effects?
Since this trial involves non-medical interventions (texting programs), there aren't typical medication side effects. However, participants may experience stress or frustration if they encounter difficulties using the technology.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month follow up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 month follow up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
HbA1c percent time in control
Secondary study objectives
LDL
blood pressure control
self-reported adherence to diabetes self-care recommendations (SCI-R)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: DD-TXTExperimental Treatment1 Intervention
Participants in this group were signed up for an interactive, tailored self-management texting protocol (DD-TXT). The DD-TXT protocol consisted of the same daily educational content as the DSE arm augmented by the following: regular two-way check-in messages about diabetes self-management behaviors, an invitation to receive messages written by other Veterans living with diabetes on demand, and a menu of optional and customizable modules (e.g., medication reminders, blood sugar and blood pressure monitoring,: physical activity reminders, weight management, and goal setting) from which participants could select messaging that supported their diabetes self-management goals. Patients could customize the timing and frequency of their messages. DD-TXT participants also received a once monthly message asking whether the messages had been helpful.
Group II: DSEActive Control1 Intervention
Participants in the comparison condition were signed up for a one-way education-only protocol called Diabetes Skilled Education-Only (DSE). DSE was comprised of 6 months of once daily one-way text messages covering standard diabetes self-management education content. Starting with the VA educational workbook entitled "Self-Care Skills for the Person with Diabetes", created in alignment with VA/DoD diabetes guidelines, we enhanced the educational content by incorporating Veteran input through a co-design process with Veterans living with diabetes and expert clinician review. DSE messages could not be customized. There was no interactive content for the DSE arm other than a once monthly message asking whether the messages had been helpful.

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,664 Previous Clinical Trials
3,765,422 Total Patients Enrolled
Stephanie L Shimada, PhDPrincipal InvestigatorVA Bedford HealthCare System, Bedford, MA
1 Previous Clinical Trials
275 Total Patients Enrolled

Media Library

DD-TXT Clinical Trial Eligibility Overview. Trial Name: NCT04227379 — N/A
Type 2 Diabetes Research Study Groups: DD-TXT, DSE
Type 2 Diabetes Clinical Trial 2023: DD-TXT Highlights & Side Effects. Trial Name: NCT04227379 — N/A
DD-TXT 2023 Treatment Timeline for Medical Study. Trial Name: NCT04227379 — N/A
~114 spots leftby Oct 2025